Abstract

BackgroundA recent randomized controlled trial in patients with rheumatoid arthritis (RA) showed non-inferiority of clinical benefit when starting on triple therapy (sulfasalazine (SSZ)+hydroxychloroqiune (HCQ)+methotrexate (MTX)) as compared to etanercept (ETN)...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Low Persistence Rates in Patients With Rheumatoid Arthritis Treated With Triple Therapy and Adverse Drug Events Associated With Sulfasalazine.
Daniel P Erhardt ... Chia‐Chen Teng
Arthritis Care & Research | VOL. 71
Daniel P Erhardt, et. al.Daniel P Erhardt ... Chia‐Chen Teng
30 Aug 2019
FRI0113 Persistence and Adherence with Triple Therapy and Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy in us Veterans with Rheumatoid Arthritis
G.W Cannon ... J Leng
Annals of the Rheumatic Diseases | VOL. 74
G.W Cannon, et. al.G.W Cannon ... J Leng
01 Jun 2015
Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
Jeffrey R Curtis ... Dimitrios A Pappas
Arthritis Care & Research | VOL. 73
Jeffrey R Curtis, et. al.Jeffrey R Curtis ... Dimitrios A Pappas
30 Jul 2021
Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study.
Eun Ha Kang ... Seoyoung C Kim
Arthritis care & research | VOL. 72
Eun Ha Kang, et. al.Eun Ha Kang ... Seoyoung C Kim
29 Sep 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Assessing the performance of AI chatbots in answering patients’ common questions about low back pain
Simone P S Scaff ... Bruno T Saragiotto
Annals of the Rheumatic Diseases | VOL. -
Simone P S Scaff, et. al.Simone P S Scaff ... Bruno T Saragiotto
18 Sep 2024
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages
Xinran Yuan ... Betty P Tsao
Annals of the Rheumatic Diseases | VOL. -
Xinran Yuan, et. al.Xinran Yuan ... Betty P Tsao
18 Sep 2024
Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders
Hao Zhou ... Ilana Brito
Annals of the Rheumatic Diseases | VOL. -
Hao Zhou, et. al.Hao Zhou ... Ilana Brito
18 Sep 2024
Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial
Elise Van Mulligen ... Annette Van Der Helm-Van Mil
Annals of the Rheumatic Diseases | VOL. -
Elise Van Mulligen, et. al.Elise Van Mulligen ... Annette Van Der Helm-Van Mil
18 Sep 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.